{
    "id": 25854,
    "fullName": "PTK6 Y447F",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PTK6 Y447F lies within the protein kinase domain of the Ptk6 protein (UniProt.org). Y447F results in increased Ptk6 kinase activity in cultured cells (PMID: 15471878, PMID: 27758886).",
            "references": [
                {
                    "id": 7466,
                    "pubMedId": 27758886,
                    "title": "Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27758886"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 7467,
                    "pubMedId": 15471878,
                    "title": "The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15471878"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5753,
        "geneSymbol": "PTK6",
        "terms": [
            "PTK6",
            "BRK"
        ]
    },
    "variant": "Y447F",
    "createDate": "01/03/2017",
    "updateDate": "01/03/2017",
    "referenceTranscriptCoordinates": {
        "id": 169037,
        "transcript": "NM_005975",
        "gDna": "chr20:g.63529552T>A",
        "cDna": "c.1340A>T",
        "protein": "p.Y447F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9680,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, XMU-MP-2 inhibited PTK6 signaling and growth of transformed cells expressing PTK6 Y447F in culture, and reduced tumor growth and induced apoptosis in xenograft models (PMID: 27758886).",
            "molecularProfile": {
                "id": 26969,
                "profileName": "PTK6 Y447F"
            },
            "therapy": {
                "id": 5154,
                "therapyName": "XMU-MP-2",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7466,
                    "pubMedId": 27758886,
                    "title": "Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27758886"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26969,
            "profileName": "PTK6 Y447F",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 169037,
            "transcript": "NM_005975",
            "gDna": "chr20:g.63529552T>A",
            "cDna": "c.1340A>T",
            "protein": "p.Y447F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}